Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELNHartmut Döhner, Bob Löwenberg, Richard A. Larson et al.|Blood|2022Cited by 3k
2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignanciesYingxi Xu, Jianxiang Wang|Journal of Hematology & Oncology|2019Cited by 188
Construction of a new anti-CD19 chimeric antigen receptor and the anti-leukemia function study of the transduced T cellsNa An, Jianxiang Wang|Oncotarget|2016Cited by 44
Identification of JL1037 as a novel, specific, reversible lysine-specific demethylase 1 inhibitor that induce apoptosis and autophagy of AML cellsShuang Liu, Jianxiang Wang, Wenting Lu et al.|Oncotarget|2017Cited by 20
Identifying ADGRG1 as a specific marker for tumor-reactive T cells in acute myeloid leukemiaYihan Mei, Jianxiang Wang|Experimental Hematology and Oncology|2024Cited by 7